NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Harmonic Inc. ("Harmonic Inc.") (NASDAQ:HLIT) concerning possible violations of federal securities laws. Harmonic reported its third quarter financial results on February 10, 2025. While the Company’s reported better-than-expected results for the quarter, […]
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/merck-co-inc-lawsuit-submission-form?prid=130252&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/gsk-lawsuit-submission-form?prid=130250&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Cardlytics, Inc. (NASDAQ:CDLX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cardlytics-lawsuit-submission-form?prid=130249&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=130246&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/regeneron-pharmaceuticals-inc-lawsuit-submission-form?prid=130247&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Olin Corporation ("Olin Corporation") (NYSE:OLN) concerning possible violations of federal securities laws. Olin issued a press on January 30, 2025, reporting its financial results for the fourth quarter of 2024. Olin also
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Micron Technology, Inc. (NASDAQ:MU) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/micron-technology-inc-lawsuit-submission-form?prid=130270&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / If you suffered a loss on your Innovative Industrial Properties, Inc. (NYSE:IIPR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/innovative-industrial-properties-inc-lawsuit-submission-form?prid=130267&wire=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK, NY / ACCESS Newswire / February 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Manhattan Associates, Inc. ("Manhattan Associates") (NASDAQ:MANH) concerning possible violations of federal securities laws. On January 28, 2025, after the market closed, Manhattan Associates published fourth quarter fiscal 2024 results and issued disappointing